TECH OUTLOOK 6AUGUST - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comAs the battle to combat the increasing incidence of lifestyle diseases and other non-communicable ailment wages, the medical and pharmaceutical leaders have shifted gears to include a plethora of medicines to tackle the condition effectively. On the flip side, these drugs are generating adverse side effects, thereby calling an imperative need to monitor the medications on an immediate basis. Enters Pharmacovigilance. Powered by sophisticated technology, pharmacovigilance is paving the way for better, faster, and accurate drug analysis both before and after its release. Incorporating advanced technologies make the pharmacovigilance systems to aid in conducting more efficient identification processes aligned to regulatory norms. For instance, several firms are infusing artificial intelligence and predictive analytics algorithms to safely manage data and enhance accuracy with increase in case volumes. In that regard, innovative automation tools and systems are streamlining end-to-end safety processes and removing redundant human involvement that complicates the operation. Standing at the cusp of pharmacovigilance services and technologies, there are a wide range of solution providers and services companies which offer the latest methods best suited for the next generation of pharma needs. To help leaders navigate through the list of pharmacovigilance service providers and solutions organizations, our panel comprising of CEOs, CIOs, VCs, industry analysts, and the editorial board of Pharma Tech Outlook has narrowed down the top companies in this landscape that exhibit competence in delivering robust pharmacovigilance innovations. Equipped with innovative technological capabilities, these enlisted firms are transforming pharma at the cloverleaf of various disruptive technologies. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology. Let us know your thoughts! Innovations Open Doors for Revamped PharmacovigilanceCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.AUGUST - 16 - 2021, Vol 07 - Issue 06 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerDavid ParkerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >